Submit an article and letter of intent
To rhochipost@gmail.com
View the application: http://rhochistj.org/RhoChiPost/application/
Below are some FAQ; please email us for any other concerns!
Who can join the Rho Chi post? Do I have to be a member of Rho Chi?
You do not have to be a member of the Rho Chi Honor Society to contribute to the newsletter. You can be in any year of your Pharmacy education to join the Rho Chi Post. In fact, any member of the College of Pharmacy and Health Sciences can join our team!
What positions can I apply for to become a permanent member of the team?
-Web based: Commitment per issue: Redesign and upkeep of the website
-Graphic based: Commitment per issue: Any graphic designing that goes into creating the issue.
-Note: for this position you need to show past editing experience.
What can I write about?
Feel free to write about any topic that interests you! Please just email us with your topic so there are no duplicates. For suggestions check out our list: http://rhochistj.org/RhoChiPost/article-signup/
*Log in username is required
How long will it take to review my application?
After we accept your article for publication, we will respond to you via email within 7 days.
Besides the article requirement, how time consuming is being a member?
We only meet a few times each semester! Most of our communications are done online. Besides the meetings just meet your monthly requirements!
Are there any dues?
No dues are required to become a member!
If you don’t want to commit to a permanent position, we welcome any submission at any time. There is no minimum or maximum to how many articles a person can submit!
By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…
By: Archana Murugan, PharmD candidate c/o 2029 Overview Thiamine metabolic dysfunction syndrome (TMDS) refers…
By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028 The…
By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…
By: Sariah Grant, PharmD Candidate c/o 2027 The rise of glucagon-like peptide -1 receptor…
By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…